BHC.US Bausch Health Companies Inc

Healthcare Pharmaceuticals USA Stocks
8.35 USD
Close of Nov 13, 2026
4.33 9.04
Market cap
USD 3.13B
P/E
-
P/B
18.78x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BHC.US undervalued?

Graham number

The Graham number of Bausch Health Companies Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bausch Health Companies Inc fundamental analysis

No fundamental analysis for Bausch Health Companies Inc yet.

Bausch Health Companies Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devic…

Full company profile